Empagliflozin in acute myocardial infarction: the EMMY trial.

Eur Heart J · 2022 · PMC9622301 · PMID 36036746

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

32 This modest NT-proBNP difference, however, was associated with a highly significant improvement in the primary clinical outcome.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.